[HTML][HTML] Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow …
MM Montero, S Domene-Ochoa, C López-Causapé… - Scientific reports, 2021 - nature.com
Abstract Ceftolozane/tazobactam (C/T) has emerged as a potential agent for the treatment of
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber …
MM Montero, S Domene-Ochoa… - Scientific …, 2021 - ui.adsabs.harvard.edu
Abstract Ceftolozane/tazobactam (C/T) has emerged as a potential agent for the treatment of
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber …
MM Montero, S Domene-Ochoa… - Scientific …, 2021 - pubmed.ncbi.nlm.nih.gov
Ceftolozane/tazobactam (C/T) has emerged as a potential agent for the treatment of
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber …
MM Montero, S Domene Ochoa… - Sci Rep. 2021 Nov 12 …, 2021 - repositori.upf.edu
Ceftolozane/tazobactam (C/T) has emerged as a potential agent for the treatment of
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber …
MM Montero, S Domene-Ochoa… - Scientific …, 2021 - docusalut.com
Ceftolozane/tazobactam (C/T) has emerged as a potential agent for the treatment of
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
[HTML][HTML] Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber …
MM Montero, S Domene-Ochoa… - Scientific …, 2021 - ncbi.nlm.nih.gov
Abstract Ceftolozane/tazobactam (C/T) has emerged as a potential agent for the treatment of
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
[引用][C] Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber …
MM Montero, S Domene-Ochoa… - Scientific …, 2021 - espace.library.uq.edu.au
Ceftolozane/tazobactam (C/T) has emerged as a potential agent for the treatment of
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber …
A Angulo-Brunet, MM Montero… - Scientific …, 2021 - portalrecerca.uab.cat
Abstract Ceftolozane/tazobactam (C/T) has emerged as a potential agent for the treatment of
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber …
MM Montero, S Domene-Ochoa… - Scientific …, 2021 - europepmc.org
Abstract Ceftolozane/tazobactam (C/T) has emerged as a potential agent for the treatment of
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber …
MM Montero, S Domene-Ochoa, C López-Causapé… - Scientific reports, 2021 - ddd.uab.cat
Ceftolozane/tazobactam (C/T) has emerged as a potential agent for the treatment of
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …
extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time …